Fall 2023 COVID-19 Policy

Note: The following applies to College Unbound cohorts in the Rhode Island area. We are currently assessing data to determine the Fall 2023 COVID policy for College Unbound cohorts in Philadelphia and Chicago. Students in these areas should stay tuned for more information.

College Unbound cares deeply about the well-being of our community of students, faculty, and staff. As such, College Unbound strongly recommends the SARS-COVID-2 vaccine and annual booster for those engaged in all inside, in-person activities.

Mask guidelines will be contingent upon the community level transmissibility rate and recommendations of the Rhode Island Department of Health (RIDOH), the Rhode Island Department of Education (RIDE) and the CDC. We reserve the right to require masks in response to public health threats including when high community transmission rates exist. We will notify CU students, faculty, and staff of new guidelines before they enter into any building where Lab classes are being held. Additionally, Lab Faculty will meet with students to determine any additional cohort-based safety protocols (for example a student may request to their Lab Faculty that masks remain even in low-transmissibility rates). The Lab Faculty may then work with the Provost’s Office to determine cohort protocols.

Any updates to CU's COVID policy will be made in consultation with health professionals. Students will be informed both on the website and through email communication of any changes. 
CU will revisit this policy as necessary throughout the school year to ensure it complies with applicable laws and executive orders and is consistent with relevant guidance from the CDC, RIDOH, and RIDE.

Vaccine Requirements Include:

  1. Received a Pfizer or Moderna COVID-19 vaccine CDC recommended booster shot, and at least fourteen (14) days have elapsed since receiving the aforementioned booster shot; or
  2. Completed the two-dose primary series of Pfizer COVID-19 vaccine within the last 5 months; or
  3. Completed the two-dose primary series of Moderna COVID-19 vaccine within the last 6 months; or
  4. Completed the one-dose primary series of Johnson & Johnson COVID-19 vaccine in the last 2 months.